Mrv0541 01131515492D 19 20 0 0 0 0 999 V2000 -0.2907 0.3398 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.0052 0.7523 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.4238 0.7523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0052 1.5773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.7197 0.3398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.1383 0.3398 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.4238 1.5773 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.7197 1.9898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4342 0.7523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.8528 0.7523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4342 1.5774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1218 -0.3746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7033 -0.3746 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 0.9467 -0.3747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2908 -1.0892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3592 -1.0892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1217 -1.8036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9467 -1.8037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0727 -0.0439 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 1 0 0 0 0 2 4 1 0 0 0 0 2 5 1 0 0 0 0 3 6 1 0 0 0 0 3 7 2 0 0 0 0 4 8 1 0 0 0 0 5 9 1 0 0 0 0 6 10 1 0 0 0 0 8 11 1 0 0 0 0 9 11 1 0 0 0 0 12 1 1 0 0 0 0 1 13 1 1 0 0 0 14 12 1 0 0 0 0 15 12 2 0 0 0 0 16 14 2 0 0 0 0 17 15 1 0 0 0 0 18 16 1 0 0 0 0 18 17 2 0 0 0 0 2 19 1 1 0 0 0 M END > CHEBI:51860 > dexmethylphenidate > A methyl phenyl(piperidin-2-yl)acetate in which both stereocentres have R configuration. It is the active enantiomer in the racemic drug methylphenidate. > 3 > methyl (R)-phenyl[(R)-piperidin-2-yl]acetate; d-threo-methylphenidate; (+)-threo-methylphenidate > methyl (2R)-phenyl[(2R)-piperidin-2-yl]acetate > dexmetilfenidato; dexmethylphenidatum; dexmethylphenidate; dexmethylphenidate > C14H19NO2 > 233.30620 > 233.14158 > 0 > COC(=O)[C@@H]([C@H]1CCCCN1)c1ccccc1 > InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1 > DUGOZIWVEXMGBE-CHWSQXEVSA-N > 6116309 > 40431-64-9 > 40431-64-9 > Dexmethylphenidate $$$$